Dr. Gottlieb is a cardiologist. He is highly skilled and experienced in the diagnosis and treatment of patients with heart failure. He also specializes in the management of cardiac amyloidosis, a buildup of abnormal proteins (amyloids) in the tissues of the heart that affects its function.
Dr. Gottlieb has been working for over a decade to develop drugs for amyloidosis treatment. He is now investigating various types of new drugs with the potential to reverse the disease. In addition to cardiac amyloidosis, his special clinical interests include cardiorenal syndrome (disorders of the heart and kidneys) and congestive heart failure. He also evaluates sleep abnormalities and the interaction of physiology and psychology in heart failure patients.
Dr. Gottlieb has been at University of Maryland School of Medicine since 1988 and is currently professor of medicine and director of the Clinical Research Program in Cardiology.
Board Certification and Education
Medical School:
The Warren Alpert Medical School of Brown University, 1981
Internship:
University of Chicago Medical Center, 1982
Residency:
University of Chicago Medical Center, 1984
Fellowship:
Mount Sinai Medical Center - Cardiology, 1987
Certification:
American Board of Internal Medicine - Cardiovascular Disease, 1987
American Board of Internal Medicine - Internal Medicine, 1984
Hospital Affiliations
University of Maryland Medical Center Midtown Campus
University of Maryland Medical Center
Research and Publications
Dr. Gottlieb’s research centers on the physiology and therapy of congestive heart failure. This includes a particular interest in neurohormonal activation and renal function in CHF patients.
Having studied the impact of adenosine antagonists and other medications and interventions on renal function and the physiology of renal function in heart failure patients, Dr. Gottlieb is interested in the interaction of heart failure and renal dysfunction. He investigates new therapies and is currently working on new inotropes, vasodilators and devices. He was the United States' principal investigator for the groundbreaking MERIT-HF evaluation of beta blockers.
Dr. Gottlieb has published about the interaction of depression and heart failure. In addition, he has investigated the effects of home telemonitoring, sleep abnormalities and genetic polymorphisms in heart failure patients.
Provider Ratings
The UMMS Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5, with 5 being the best score.
There are no ratings for this provider.
UMMS Providers with fewer than 30 ratings do not meet qualifications to display a rating.
